Anti-inflammatory effects of iridoid glycosides fraction of Folium syringae leaves on TNBS-induced colitis in rats

被引:87
作者
Liu, Xin [1 ]
Wang, Jianming [2 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China
[2] Heilongjiang Univ Chinese Med, Acad Tradit Chinese Med, Harbin 150040, Peoples R China
关键词
Iridoid glycosides; Ulcerative colitis; Oxidative damage; Inflammatory cytokines; Nuclear factor NF-kappa B p65; DEXTRAN-SULFATE-SODIUM; NITRIC-OXIDE SYNTHASE; FACTOR-KAPPA-B; INFLAMMATION; ASSAY; MICE;
D O I
10.1016/j.jep.2010.11.010
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Aim of the study: To investigate the effects and the protective mechanism of iridoid glycosides (IC) enriched from Folium syringae leaves on ulcerative colitis (UC) model induced by 2,4,6-trinitrobenzenesulfonic acid (TNBS) in rats. Materials and methods: UC in rats was induced by colonic administration with TNBS. IC (80. 160 and 240 mg/kg) was administered for 2 week to experimental colitis rats. The inflammatory degree was assessed by macroscopic score, histology and myeloperoxidase (MPO) activity. Nitric oxide (NO) and malondialdehyde (mDA) levels were measured with biochemical methods. The protein expressions of nuclear factor-kappaBp65 (NF-kappa Bp65) and mRNA expressions of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and NF-kappa Bp65, were determined by immunohistochemistry and real-time quantitative PCR, respectively. Results: IC significantly ameliorated macroscopic damage and histological changes, reduced the activity of MPO, depressed MDA and NO levels and effectively inhibited the protein and mRNA expressions of NF-kappa Bp65,TNF-alpha and IL-6 in the colon tissues of experimental colitis in a dose-dependent manner. Moreover, the effects of IC (160 mg/kg and 240 mg/kg) were superior to salicylazosulfapyridine (150 mg/kg). Conclusion: We demonstrated for the first time that IG possessed marked protective effects on experimental colitis through its antioxidation and inhibiting inflammatory mediators by down-regulation of the expressions of NF-kappa Bp65. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:780 / 787
页数:8
相关论文
共 28 条
  • [1] NF-κB in inflammatory bowel disease
    Atreya, I.
    Atreya, R.
    Neurath, M. F.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2008, 263 (06) : 591 - 596
  • [2] Effects of tumour necrosis factor-α synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis
    Bobin-Dubigeon, C
    Collin, X
    Grimaud, N
    Robert, JM
    Le Baut, G
    Petit, JY
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 431 (01) : 103 - 110
  • [3] Peroxynitrite increases iNOS through NF-κB and decreases prostacyclin synthase in endothelial cells
    Cooke, CLM
    Davidge, ST
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2002, 282 (02): : C395 - C402
  • [4] Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby & Grimes in TNBS colitis model
    da Silva, Maria Silene
    Sanchez-Fidalgo, Susana
    Talero, Elena
    Cardeno, Ana
    da Silva, Marcelo Aparecido
    Villegas, Wagner
    Monteiro Souza Brito, Alba Regina
    Alarcon de La Lastra, Catalina
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2010, 128 (02) : 467 - 475
  • [5] Effects of trimetazidine on oxidant/antioxidant status in trinitrobenzenesulfonic acid-induced chronic colitis
    Girgin, F
    Karaoglu, Ö
    Erkus, M
    Tüzün, S
    Özütemiz, Ö
    Dinçer, Ç
    Batur, Y
    Tanyalçin, T
    [J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2000, 59 (08): : 641 - 652
  • [6] Anti-inflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice
    Islam, M. S.
    Murata, T.
    Fujisawa, M.
    Nagasaka, R.
    Ushio, H.
    Bari, A. M.
    Hori, M.
    Ozaki, H.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (04) : 812 - 824
  • [7] Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease
    Kimura, H
    Miura, S
    Shigematsu, T
    Ohkubo, N
    Tsuzuki, Y
    Kurose, I
    Higuchi, H
    Akiba, Y
    Hokari, R
    Hirokawa, M
    Serizawa, H
    Ishii, H
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (05) : 1047 - 1054
  • [8] Treatment of inflammatory bowel disease: A review of medical therapy
    Kozuch, Patricia L.
    Hanauer, Stephen B.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (03) : 354 - 377
  • [9] KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344
  • [10] KURUTAS EB, 2005, MEDIATORS INFLAMATIO, V6, P390, DOI DOI 10.1155/MI.2005.390